Literature DB >> 34861039

Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome.

Courtnee A Clough1,2, Joseph Pangallo1,3,4, Martina Sarchi2,5, Janine O Ilagan3,4, Khrystyna North3,4,6, Rochelle Bergantinos2, Massiel C Stolla2, Jasmine Naru7,8, Patrick Nugent1,3,4, Eunhee Kim9,10, Derek L Stirewalt7,8, Arvind R Subramaniam3,4, Omar Abdel-Wahab9,11, Janis L Abkowitz2,6,12, Robert K Bradley3,4,6, Sergei Doulatov2,6,12.   

Abstract

SF3B1 splicing factor mutations are near-universally found in myelodysplastic syndromes (MDS) with ring sideroblasts (RS), a clonal hematopoietic disorder characterized by abnormal erythroid cells with iron-loaded mitochondria. Despite this remarkably strong genotype-to-phenotype correlation, the mechanism by which mutant SF3B1 dysregulates iron metabolism to cause RS remains unclear due to an absence of physiological models of RS formation. Here, we report an induced pluripotent stem cell model of SF3B1-mutant MDS that for the first time recapitulates robust RS formation during in vitro erythroid differentiation. Mutant SF3B1 induces missplicing of ∼100 genes throughout erythroid differentiation, including proposed RS driver genes TMEM14C, PPOX, and ABCB7. All 3 missplicing events reduce protein expression, notably occurring via 5' UTR alteration, and reduced translation efficiency for TMEM14C. Functional rescue of TMEM14C and ABCB7, but not the non-rate-limiting enzyme PPOX, markedly decreased RS, and their combined rescue nearly abolished RS formation. Our study demonstrates that coordinated missplicing of mitochondrial transporters TMEM14C and ABCB7 by mutant SF3B1 sequesters iron in mitochondria, causing RS formation.
© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34861039      PMCID: PMC8972092          DOI: 10.1182/blood.2021012652

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  44 in total

1.  Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.

Authors:  Mario Cazzola; Rosangela Invernizzi; Gaetano Bergamaschi; Sonia Levi; Barbara Corsi; Erica Travaglino; Valeria Rolandi; Giorgio Biasiotto; Jim Drysdale; Paolo Arosio
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

2.  A defined culture method enabling the establishment of ring sideroblasts from induced pluripotent cells of X-linked sideroblastic anemia.

Authors:  Shunsuke Hatta; Tohru Fujiwara; Takako Yamamoto; Kei Saito; Mayumi Kamata; Yoshiko Tamai; Shin Kawamata; Hideo Harigae
Journal:  Haematologica       Date:  2018-02-01       Impact factor: 9.941

3.  Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.

Authors:  Mario Cazzola; Luca Malcovati
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

4.  Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations.

Authors:  Andrea Pellagatti; Richard N Armstrong; Violetta Steeples; Eshita Sharma; Emmanouela Repapi; Shalini Singh; Andrea Sanchi; Aleksandar Radujkovic; Patrick Horn; Hamid Dolatshad; Swagata Roy; John Broxholme; Helen Lockstone; Stephen Taylor; Aristoteles Giagounidis; Paresh Vyas; Anna Schuh; Angela Hamblin; Elli Papaemmanuil; Sally Killick; Luca Malcovati; Marco L Hennrich; Anne-Claude Gavin; Anthony D Ho; Thomas Luft; Eva Hellström-Lindberg; Mario Cazzola; Christopher W J Smith; Stephen Smith; Jacqueline Boultwood
Journal:  Blood       Date:  2018-06-21       Impact factor: 22.113

5.  Before It Gets Started: Regulating Translation at the 5' UTR.

Authors:  Patricia R Araujo; Kihoon Yoon; Daijin Ko; Andrew D Smith; Mei Qiao; Uthra Suresh; Suzanne C Burns; Luiz O F Penalva
Journal:  Comp Funct Genomics       Date:  2012-05-28

Review 6.  The molecular genetics of sideroblastic anemia.

Authors:  Sarah Ducamp; Mark D Fleming
Journal:  Blood       Date:  2018-11-06       Impact factor: 25.476

7.  Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms.

Authors:  Justin Taylor; Xiaoli Mi; Khrystyna North; Moritz Binder; Alexander Penson; Terra Lasho; Katherine Knorr; Michael Haddadin; Bo Liu; Joseph Pangallo; Salima Benbarche; Daniel Wiseman; Ayalew Tefferi; Stephanie Halene; Yang Liang; Mrinal M Patnaik; Robert K Bradley; Omar Abdel-Wahab
Journal:  Blood       Date:  2020-09-24       Impact factor: 25.476

Review 8.  SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.

Authors:  Luca Malcovati; Kristen Stevenson; Elli Papaemmanuil; Donna Neuberg; Rafael Bejar; Jacqueline Boultwood; David T Bowen; Peter J Campbell; Benjamin L Ebert; Pierre Fenaux; Torsten Haferlach; Michael Heuser; Joop H Jansen; Rami S Komrokji; Jaroslaw P Maciejewski; Matthew J Walter; Michaela Fontenay; Guillermo Garcia-Manero; Timothy A Graubert; Aly Karsan; Manja Meggendorfer; Andrea Pellagatti; David A Sallman; Michael R Savona; Mikkael A Sekeres; David P Steensma; Sudhir Tauro; Felicitas Thol; Paresh Vyas; Arjan A Van de Loosdrecht; Detlef Haase; Heinz Tüchler; Peter L Greenberg; Seishi Ogawa; Eva Hellstrom-Lindberg; Mario Cazzola
Journal:  Blood       Date:  2020-07-09       Impact factor: 25.476

9.  Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.

Authors:  Simona Conte; Shintaro Katayama; Liselotte Vesterlund; Mohsen Karimi; Marios Dimitriou; Monika Jansson; Teresa Mortera-Blanco; Per Unneberg; Elli Papaemmanuil; Birgitta Sander; Tiina Skoog; Peter Campbell; Julian Walfridsson; Juha Kere; Eva Hellström-Lindberg
Journal:  Br J Haematol       Date:  2015-08-10       Impact factor: 6.998

10.  A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes.

Authors:  Edda María Elvarsdóttir; Teresa Mortera-Blanco; Marios Dimitriou; Thibault Bouderlique; Monika Jansson; Isabel Juliana F Hofman; Simona Conte; Mohsen Karimi; Birgitta Sander; Iyadh Douagi; Petter S Woll; Eva Hellström-Lindberg
Journal:  Leukemia       Date:  2019-08-02       Impact factor: 11.528

View more
  4 in total

Review 1.  Regulation of Heme Synthesis by Mitochondrial Homeostasis Proteins.

Authors:  Yvette Y Yien; Mark Perfetto
Journal:  Front Cell Dev Biol       Date:  2022-06-27

2.  Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis.

Authors:  Koya Ono; Tohru Fujiwara; Kei Saito; Hironari Nishizawa; Noriyuki Takahashi; Chie Suzuki; Tetsuro Ochi; Hiroki Kato; Yusho Ishii; Koichi Onodera; Satoshi Ichikawa; Noriko Fukuhara; Yasushi Onishi; Hisayuki Yokoyama; Rie Yamada; Yukio Nakamura; Kazuhiko Igarashi; Hideo Harigae
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

3.  Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome.

Authors:  Tetsuro Ochi; Tohru Fujiwara; Koya Ono; Chie Suzuki; Maika Nikaido; Daichi Inoue; Hiroki Kato; Koichi Onodera; Satoshi Ichikawa; Noriko Fukuhara; Yasushi Onishi; Hisayuki Yokoyama; Yukio Nakamura; Hideo Harigae
Journal:  Sci Rep       Date:  2022-08-26       Impact factor: 4.996

Review 4.  SF3B1 Mutations in Hematological Malignancies.

Authors:  Daniela Cilloni; Federico Itri; Valentina Bonuomo; Jessica Petiti
Journal:  Cancers (Basel)       Date:  2022-10-08       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.